超过5%股东持股披露「修订」
Design Therapeutics(DSGN)09-07 21:45
$Design Therapeutics(DSGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001306550-23-009874 Act: 34 Size: 12 KB 网页链接
| 今开：2.41 | 昨收：2.405 |
| 最高：2.43 | 最低：2.38 |
| 涨停价： | 跌停价： |
| 总市值：134367977 |
Design Therapeutics(DSGN)09-07 21:45
$Design Therapeutics(DSGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001306550-23-009874 Act: 34 Size: 12 KB 网页链接
Design Therapeutics(DSGN)09-07 05:15
$Design Therapeutics(DSGN)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-048441 Size: 10 KB 网页链接
Design Therapeutics(DSGN)09-06 05:35
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-048222 Size: 10 KB 网页链接
Design Therapeutics(DSGN)08-31 06:05
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047773 Size: 10 KB 网页链接
Design Therapeutics(DSGN)08-26 05:05
$Design Therapeutics(DSGN)$ 8-K Current report, item 5.02 Accession Number: 0001193125-23-221586 Act: 34 Size: 153 KB 网页链接
Design Therapeutics(DSGN)08-31 06:15
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047774 Size: 5 KB 网页链接
BT财经08-17 17:45
【BT机构股评】生物制药公司Design Therapeutics股票评级下调
SVB Securities将生物制药公司Design Therapeutics的股票评级从“跑赢大盘”下调至“与大盘持平”，并将其目标价从22美元下调至6美元。此前，该公司公布的DT-216治疗弗里德赖希共济失调（Friedreich's ataxia）的i期MAD研究数...
Design Therapeutics(DSGN)08-15 04:15
$Design Therapeutics(DSGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-042411 Act: 34 Size: 8 MB 网页链接
Design Therapeutics(DSGN)08-15 04:15
$Design Therapeutics(DSGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-042392 Act: 34 Size: 404 KB 网页链接
Design Therapeutics(DSGN)06-03 04:35
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-033778 Size: 5 KB 网页链接
BT财经08-17 17:45
【BT机构股评】生物制药公司Design Therapeutics股票评级下调
SVB Securities将生物制药公司Design Therapeutics的股票评级从“跑赢大盘”下调至“与大盘持平”，并将其目标价从22美元下调至6美元。此前，该公司公布的DT-216治疗弗里德赖希共济失调（Friedreich's ataxia）的i期MAD研究数...查看全文
薛定锷之猫02-21 06:27
$Design Therapeutics(DSGN)$ 贝壳兄弟在退出？大幅减仓查看全文
anos2021-05-06 15:29
$Design Therapeutics(DSGN)$
Design Therapeutics(DSGN)-基本面介绍 网页链接查看全文
牛唐2021-04-30 22:14
$Design Therapeutics(DSGN)$ 又一个30%的收益，棒棒哒。$蔚来(NIO)$ $百度(BIDU)$查看全文
chuminhua2021-03-28 12:07
3月26日，Design Therapeutics、Edgewise Therapeutics、Ikena Oncology和Universe Pharmaceuticals（大自然药业）都在周五登陆纳斯达克。前三家分别收获了超过1亿美元的资金，其中Design募集了2.4亿美元，Edgewise净赚了1.76亿美元，Ikena则成功募集了1.25亿美元。Universe打入2500万美元。
D...查看全文
$Design Therapeutics(DSGN)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001306550-23-009874 Act: 34 Size: 12 KB 网页链接
$Design Therapeutics(DSGN)$ 4/A [Amend] Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-048441 Size: 10 KB 网页链接
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-048222 Size: 10 KB 网页链接
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047774 Size: 5 KB 网页链接
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-047773 Size: 10 KB 网页链接
$Design Therapeutics(DSGN)$ 8-K Current report, item 5.02 Accession Number: 0001193125-23-221586 Act: 34 Size: 153 KB 网页链接
$Design Therapeutics(DSGN)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0000950170-23-042392 Act: 34 Size: 404 KB 网页链接
$Design Therapeutics(DSGN)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0000950170-23-042411 Act: 34 Size: 8 MB 网页链接
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-033847 Size: 5 KB 网页链接
$Design Therapeutics(DSGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-033778 Size: 5 KB 网页链接